CeriBell
Yahoo Finance • 15 days ago
Global AI Infrastructure Shift Ignites Biotech Growth Phase
Issued on behalf of Aleen Inc. VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Last month marked a major turning point as Google launched Gemini 3[1], proving that new AI models can now ou... Full story
Yahoo Finance • last month
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story
Yahoo Finance • last month
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story
Yahoo Finance • 2 months ago
CeriBell raises 2025 revenue guidance to $89M while targeting deeper hospital penetration and expanding pediatric market
Earnings Call Insights: CeriBell, Inc. (CBLL) Q3 2025 MANAGEMENT VIEW * CEO Xingjuan Chao reported continued execution on growth initiatives and described CeriBell as the “category leader in the point-of-care EEG.” Chao highlighted a 3... Full story
Yahoo Finance • 2 months ago
CeriBell GAAP EPS of $0.37, revenue of $22.6M
* CeriBell press release [https://seekingalpha.com/pr/20293154-ceribell-reports-third-quarter-2025-financial-results] (CBLL [https://seekingalpha.com/symbol/CBLL]): Q3 GAAP EPS of $0.37. * Revenue of $22.6M. MORE ON CERIBELL * Seek... Full story
Yahoo Finance • 2 months ago
Ceribell Reports Third Quarter 2025 Financial Results
SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today re... Full story
Yahoo Finance • 2 months ago
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story
Yahoo Finance • 3 months ago
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological co... Full story
Yahoo Finance • 4 months ago
J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT
CeriBell, Inc. (NASDAQ:CBLL) is one of the best medical device stocks to buy according to analysts. J.P. Morgan analyst Robbie Marcus maintained a Buy rating on CeriBell, Inc. (NASDAQ:CBLL) on August 5, setting a price target of $21.00.5 F... Full story
Yahoo Finance • 5 months ago
CeriBell GAAP EPS of -$0.38 beats by $0.02, revenue of $21.2M beats by $0.75M
* CeriBell press release [https://seekingalpha.com/pr/20190071-ceribell-reports-second-quarter-2025-financial-results] (NASDAQ:CBLL [https://seekingalpha.com/symbol/CBLL]): Q2 GAAP EPS of -$0.38 beats by $0.02. * Revenue of $21.2M (+38... Full story
Yahoo Finance • 5 months ago
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story
Yahoo Finance • 5 months ago
CeriBell shares drop 38% following InvestingPro's overvaluation warning
In October 2024, InvestingPro’s Fair Value model identified significant overvaluation in CeriBell, Inc. (NASDAQ:CBLL), a healthcare technology company specializing in seizure diagnostic solutions. The subsequent price movement has strongly... Full story
Yahoo Finance • 6 months ago
Ceribell (CBLL) CEO Chao sells $442,500 in stock
Ceribell, Inc. (CBLL) President and CEO Chao Xingjuan, sold 25,000 shares of common stock on July 7, 2025, for a total of $442,500. The shares were sold at prices ranging from $17.02 to $18.7. The transaction comes as the stock, currently... Full story
Yahoo Finance • 6 months ago
Ceribell sues Natus Medical for patent infringement
[Judge gavel and law books in court background] CeriBell (NASDAQ:CBLL [https://seekingalpha.com/symbol/CBLL]) said on Monday that it has taken legal action against Natus Medical and its units, claiming that they have infringed on its pate... Full story
Yahoo Finance • 6 months ago
Ceribell files patent infringement complaints against Natus Medical
SUNNYVALE, Calif. - Medical technology company Ceribell, Inc. (NASDAQ:CBLL), currently valued at $684 million, announced Monday it has filed complaints against Natus Medical Incorporated, alleging patent infringement and unfair competition... Full story
Yahoo Finance • 6 months ago
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
SUNNYVALE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a leading medical technology company transforming the diagnosis and management of patients with serious neurological conditions, announced t... Full story
Yahoo Finance • 6 months ago
CeriBell a new buy at BTIG on growth in EEG monitoring system
[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov BTIG has initiated CeriBell (NASDAQ:CBLL [https://seekingalpha.com/symbol/CBLL]) with a buy rating saying that the company's point-of-care rapid electroencephalogram... Full story
Yahoo Finance • 6 months ago
BTIG initiates Ceribell stock with Buy rating on AI-driven EEG system
Investing.com - BTIG initiated coverage on Ceribell (NASDAQ:CBLL) Tuesday with a Buy rating and a $30.00 price target, citing the company’s point-of-care EEG monitoring system powered by proprietary AI technology. The Ceribell System uses... Full story
Yahoo Finance • 6 months ago
Ceribell director Robertson sells $330k in shares
Director Rebecca B. Robertson of Ceribell, Inc. (CBLL), a medical technology company currently valued at $643 million, recently sold 18,633 shares of common stock for approximately $330,961. According to InvestingPro analysis, the company... Full story
Yahoo Finance • 7 months ago
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today ann... Full story
